Engineering Nano‐Therapeutics to Boost Adoptive Cell Therapy for Cancer Treatment

Cites (226)

Items 201–222 of 222

1. Evolution of CAR T-cell immunotherapy in terms of patenting activity
   Björn Jürgens, Nigel S. Clarke · 2019 · Nature Biotechnology
2. Labelling dendritic cells with SPIO has implications for their subsequent in vivo migration as assessed with cellular MRI
   Sonali N. de Chickera, Jonatan A. Snir, Christy Willert, Roja Rohani, Ronan Foley, Paula J. Foster, Gregory A. Dekaban · 2011 · Contrast Media & Molecular Imaging
3. Adoptive transfer of pTRP2-specific CTLs expanding by bead-based artificial antigen-presenting cells mediates anti-melanoma response
   Xiaoling Lü, Xiaobing Jiang, Ru-en Liu, Hongyang Zhao, Zhihui Liang · 2008 · Cancer Letters
4. Combining Adhesive Nanostructured Surfaces and Costimulatory Signals to Increase T Cell Activation
   Judith Guasch, Marco Hoffmann, Jennifer Diemer, Hossein Riahinezhad, Stefanie Neubauer, Horst Kessler, Joachim Pius Spatz · 2018 · Nano Letters
5. Massive clonal expansion of medulloblastoma-specific T cells during adoptive cellular therapy
   Catherine Flores, Tyler J. Wildes, Bayli DiVita Dean, Ginger L. Moore, Jeffrey A. Drake, Rebecca S. Abraham, Jorge N. Gil, Oleg Yegorov, Changlin Yang, Joseph W. Dean et al. · 2019 · Science Advances
6. Adoptive T cell cancer therapy
   Karine N. Dzhandzhugazyan, Per Guldberg, Alexei F. Kirkin · 2018 · Nature Materials
7. HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagement
   Mathias Oelke, Jonathan P. Schneck · 2004 · Clinical Immunology
8. Nanoparticles and Antigen-Specific T-Cell Therapeutics: A Comprehensive Study on Uptake and Release
   Oliver Zupke, Eva Distler, Anna Jürchott, Umaporn Paiphansiri, Martin Dass, Simone Thomas, Udo F. Hartwig, Matthias Theobald, Katharina Landfester, Volker Mailänder et al. · 2015 · Nanomedicine
9. HLA Tetramer–Based Artificial Antigen-Presenting Cells Efficiently Stimulate CTLs Specific for Malignant Glioma
   Xiaobing Jiang, Xiaoling Lü, Ruen Liu, Fangcheng Zhang, Hongyang Zhao · 2007 · Clinical Cancer Research
10. A novel phosphoester-based cationic co-polymer nanocarrier delivers chimeric antigen receptor plasmid and exhibits anti-tumor effect
    Jing Fan, Qianjun He, Zhaokui Jin, Wei Chen, Weiren Huang · 2018 · RSC Advances
11. Synthetic, Supramolecular, and Self‐Adjuvanting CD8 + T‐Cell Epitope Vaccine Increases the Therapeutic Antitumor Immunity
    Pengxiang Yang, Huijuan Song, Zujian Feng, Changrong Wang, Pingsheng Huang, Chuangnian Zhang, Deling Kong, Weiwei Wang · 2019 · Advanced Therapeutics
12. The migration of synthetic magnetic nanoparticle labeled dendritic cells into lymph nodes with optical imaging
    Yongbin Mou, Hang Su, Yanli An, Wei Han, Xiaofeng Huang, Guohua Xia, Yanhong Ni, Yu Xin Zhang, Jianmin Ma, Qingang Hu · 2013 · International Journal of Nanomedicine
13. Improving cell-based therapies by nanomodification
    Wei Chen, Liwu Fu, Xiaoyuan Chen · 2015 · Journal of Controlled Release
14. Improving Tumor Retention of Effector Cells in Adoptive Cell Transfer Therapies by Magnetic Targeting
    Laura Sanz-Ortega, José Manuel Rojas, Domingo Francisco Barber · 2020 · Pharmaceutics
15. Modulating T-cell-based cancer immunotherapy via particulate systems
    Duy Hieu Truong, Thi Thu Phuong Tran, Hanh Thuy Nguyen, Cao Dai Phung, Tung Thanh Pham, Chul Soon Yong, Jong Oh Kim, Tuan Hiep Tran · 2018 · Journal of drug targeting
16. Lymphocyte recognition of H‐2 antigen in liposomes
    Steven H Herrmann, Matthew F. Mescher · 1981 · Journal of Supramolecular Structure and Cellular Biochemistry
17. Absorbable microparticulate cation exchanger for immunotherapeutic delivery
    Waleed S.W. Shalaby, Heidi Yeh, Edward Y. Woo, Joel T. Corbett, Heidi J. Gray, Carl H. June, Shalaby W. Shalaby · 2004 · Journal of Biomedical Materials Research Part B Applied Biomaterials
18. Abstract 3718: An injectable nanoparticle formulation of valrubicin
    Tapas De, Steve Miller, Zachary Yim, Vuong N. Trieu · 2018 · Cancer Research
19. Artificial Antigen-Presenting Cells for Immunotherapies
    Alyssa L. Siefert, Tarek M. Fahmy, Dongin Kim · 2017 · Methods in molecular biology
20. Imaging Adoptive Cell Transfer Based Cancer Immunotherapy
    Brian A. Rabinovich, Caius G. Radu · 2010 · Current Pharmaceutical Biotechnology
21. Randomized phase III study comparing non-myeloablative lymphocyte depleting regimen of chemotherapy followed by infusion of tumor-infiltrating lymphocytes and interleukin-2 to standard ipilimumab treatment in metastatic melanoma.
    Marnix H. Geukes Foppen, Marco Donia, Troels Holz Borch, Özcan Met, Christian U. Blank, Loes M. Pronk, Johannes V. van Thienen, Inge Marie Svane, John B.A.G. Haanen · 2016 · Journal of Clinical Oncology
22. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas
    Demark-Wahnefried, Wendy, Peterson, Bercedis, McBride, Colleen, Lipkus, Isaac, Clipp, Elizabeth · 2000 · Cancer